MedPath

Comparing different medicines for preventing fits/seizures /convulsions in accident patients

Phase 4
Recruiting
Conditions
Unspecified intracranial injury,
Registration Number
CTRI/2023/11/060169
Lead Sponsor
Hospital supplyfree of cost Sherikashmir institute of medical sciences
Brief Summary

Traumatic brain injury is one of the leading causes of death and disability through out the world .Occurance of seizures can worsen the outcome in these patients. Though TBI guidelines advocate the use of phenytoin for early onset seizures in TBI, there is emerging evidence that the use of the broad spectrum drugs as leveteracitam may be helpful in ameliorating the seizures in the early postoperative period .This pilot study is being done to compare phenytoin with levetiracetam for prophylaxis of seizures in TBI patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
30
Inclusion Criteria

1)Pts 18yrs or above 2)Pts with diagnosis of TBI 3)GCS less than 8.

Exclusion Criteria
  • 1)Pts with history of epilepsy or seizure disorder.
  • 2)Pt with history of hypersensitivity or allergy to phenytoin or leviteracetam.
  • 3)Pt with history of liver or kidney disease.
  • 4)Pts who are pregnant or breast feeding.
  • 5)Pts who don’t give consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)Time to first seizureDuring 7 days
2)total seizures during 7 daysDuring 7 days
Secondary Outcome Measures
NameTimeMethod
No. of days of icu stay.No. of days of hospital stay

Trial Locations

Locations (1)

Sheri Kashmir Institute of medical Sciences Soura

🇮🇳

JAMMU, & KASHMIR, India

Sheri Kashmir Institute of medical Sciences Soura
🇮🇳JAMMU, & KASHMIR, India
Dr Zulfiqar Ali
Principal investigator
9419086761
zulfiqaraliiii@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.